NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal
5 (653) · $ 11.50 · In stock
An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.
Frontiers Reduced immunogenicity of a live Salmonella enterica
Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and
Vaccines platforms and COVID-19: what you need to know
Adjuvant Development Program NIAID: National Institute of
Vaccine value profile for enterotoxigenic Escherichia coli (ETEC
Key roles of adjuvants in modern vaccines - Document - Gale
Accelerating Next-Generation Vaccine Development for Global
Global Innovations (International Cooperation
Vaccines, Free Full-Text
Intestinal helminth infection impairs oral and parenteral vaccine
Vaccines platforms and COVID-19: what you need to know
Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and
PDF) Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to
Intestinal helminth infection impairs oral and parenteral vaccine
